A PET/CT-based 3D deep learning model for predicting spread through air spaces in stage I lung adenocarcinoma.

IF 2.5 3区 医学 Q2 ONCOLOGY Clinical & Translational Oncology Pub Date : 2025-08-01 Epub Date: 2025-02-24 DOI:10.1007/s12094-025-03870-9
Cheng Zheng, Yujie Cai, Jiangfeng Miao, BingShu Zheng, Yan Gao, Chen Shen, ShanLei Bao, ZhongHua Tan, ChunFeng Sun
{"title":"A PET/CT-based 3D deep learning model for predicting spread through air spaces in stage I lung adenocarcinoma.","authors":"Cheng Zheng, Yujie Cai, Jiangfeng Miao, BingShu Zheng, Yan Gao, Chen Shen, ShanLei Bao, ZhongHua Tan, ChunFeng Sun","doi":"10.1007/s12094-025-03870-9","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>This study evaluates a three-dimensional (3D) deep learning (DL) model based on fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) for predicting the preoperative status of spread through air spaces (STAS) in patients with clinical stage I lung adenocarcinoma (LUAD).</p><p><strong>Methods: </strong>A retrospective analysis of 162 patients with stage I LUAD was conducted, splitting data into training and test sets (4:1). Six 3D DL models were developed, and the top-performing PET and CT models (ResNet50) were fused for optimal prediction. The model's clinical utility was assessed through a two-stage reader study.</p><p><strong>Results: </strong>The fused PET/CT model achieved an area under the curve (AUC) of 0.956 (95% CI 0.9230-0.9881) in the training set and 0.889 (95% CI 0.7624-1.0000) in the test set. Compared to three physicians, the model demonstrated superior sensitivity and specificity. After the artificial intelligence (AI) assistance's participation, the diagnostic accuracy of the physicians improved during their subsequent reading session.</p><p><strong>Conclusion: </strong>Our DL model demonstrates potential as a resource to aid physicians in predicting STAS status and preoperative treatment planning for stage I LUAD, though prospective validation is required.</p>","PeriodicalId":50685,"journal":{"name":"Clinical & Translational Oncology","volume":" ","pages":"3364-3374"},"PeriodicalIF":2.5000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical & Translational Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12094-025-03870-9","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/24 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: This study evaluates a three-dimensional (3D) deep learning (DL) model based on fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) for predicting the preoperative status of spread through air spaces (STAS) in patients with clinical stage I lung adenocarcinoma (LUAD).

Methods: A retrospective analysis of 162 patients with stage I LUAD was conducted, splitting data into training and test sets (4:1). Six 3D DL models were developed, and the top-performing PET and CT models (ResNet50) were fused for optimal prediction. The model's clinical utility was assessed through a two-stage reader study.

Results: The fused PET/CT model achieved an area under the curve (AUC) of 0.956 (95% CI 0.9230-0.9881) in the training set and 0.889 (95% CI 0.7624-1.0000) in the test set. Compared to three physicians, the model demonstrated superior sensitivity and specificity. After the artificial intelligence (AI) assistance's participation, the diagnostic accuracy of the physicians improved during their subsequent reading session.

Conclusion: Our DL model demonstrates potential as a resource to aid physicians in predicting STAS status and preoperative treatment planning for stage I LUAD, though prospective validation is required.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
基于PET/ ct的三维深度学习模型用于预测I期肺腺癌通过空气空间的扩散。
目的:本研究评估基于氟-18氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(18F-FDG PET/CT)的三维(3D)深度学习(DL)模型预测临床I期肺腺癌(LUAD)患者术前通过空气间隙扩散(STAS)状态。方法:对162例I期LUAD患者进行回顾性分析,将数据分为训练集和测试集(4:1)。建立了6个3D深度DL模型,并融合了表现最好的PET和CT模型(ResNet50)以进行最佳预测。该模型的临床效用通过两个阶段的读者研究进行评估。结果:PET/CT融合模型在训练集的曲线下面积(AUC)为0.956 (95% CI 0.9230 ~ 0.9881),在测试集的AUC为0.889 (95% CI 0.7624 ~ 1.0000)。与三位医生相比,该模型表现出更高的敏感性和特异性。在人工智能(AI)辅助的参与下,医生在随后的阅读过程中诊断的准确性得到了提高。结论:尽管需要前瞻性验证,但我们的DL模型显示了作为一种资源来帮助医生预测STAS状态和I期LUAD的术前治疗计划的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
6.20
自引率
2.90%
发文量
240
审稿时长
1 months
期刊介绍: Clinical and Translational Oncology is an international journal devoted to fostering interaction between experimental and clinical oncology. It covers all aspects of research on cancer, from the more basic discoveries dealing with both cell and molecular biology of tumour cells, to the most advanced clinical assays of conventional and new drugs. In addition, the journal has a strong commitment to facilitating the transfer of knowledge from the basic laboratory to the clinical practice, with the publication of educational series devoted to closing the gap between molecular and clinical oncologists. Molecular biology of tumours, identification of new targets for cancer therapy, and new technologies for research and treatment of cancer are the major themes covered by the educational series. Full research articles on a broad spectrum of subjects, including the molecular and cellular bases of disease, aetiology, pathophysiology, pathology, epidemiology, clinical features, and the diagnosis, prognosis and treatment of cancer, will be considered for publication.
期刊最新文献
The prognostic value of methylated ctDNA, soluble PD-L1, and NK-cell activity on the risk of relapse after curative radiotherapy of non-small cell lung cancer. AURKB drives aggressive phenotype and clinicopathological progression in cholangiocarcinoma. Challenging esophageal surgery: risk factors, outcomes, and a comparative single-center analysis. FAT4 loss promotes tumor growth and ferroptosis resistance in hepatocellular carcinoma via PI3K/AKT pathway activation. The early diagnostic value of lung cancer autoantibodies and tumor markers in lung cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1